Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FKD38
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,355
Award facts
- Contract value 100% obligated
- $27,355.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $27.4K to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on September 26, 2025, with completion targeted for September 29, 2025. This firm fixed-price delivery order, placed without set-aside designation, demonstrates competitive procurement of pharmaceutical products for military healthcare needs. The award is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1B vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for federal medical supply requirements.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical deliveries through the DLA, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Gemtesa, a medication used in urology treatment, reflects the company's demonstrated capability to fulfill federal procurement requirements through competitive processes and reinforces its role as a primary pharmaceutical supplier within the Defense Health Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FKD38?
SPE2DB25FKD38 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FKD38 worth?
The government has obligated $27,355 on SPE2DB25FKD38.
Is contract SPE2DB25FKD38 an order under another contract?
Yes. SPE2DB25FKD38 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKD38 competed?
The extent of competition for SPE2DB25FKD38 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award